Department of Biotechnology, School of Biotechnology, KIIT University, Bhubaneswar, Odisha, India
Review Article
New Approaches in the Diagnosis and Treatment of Latent Tuberculosis in Public Healthcare Facilities of India: An Insight Review
Author(s): Braja Sundar Barik, Shally Pandit, Sudatta Chandan, Tahziba Hussain*, Sasmita Nayak and Sanghamitra Pati
According to the World Health Organization, diagnosing and treating Latent Tuberculosis Infection (LTBI) is a crucial strategy for accelerating the worldwide TB epidemic's decline and achieving TB eradication. Several obstacles have impeded the implementation or expansion of LTBI treatment programs, even in low-TB burden nations that have attained high rates of identification and successful treatment for active TB. The existing diagnostic tests have a low predictive value and only a small percentage of TB infection cases progress to active disease. Due to the lengthy duration of therapy and uncomfortable side effects, isoniazid (INH) treatment for LTBI has a low completion rate. Patients and medical professionals frequently believe that the danger of toxicity is greater than the chance of TB reactivation. As a result, outside of nations with abundant resources and low illness burd.. View More»
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 